Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1706-1709

  Turner, Joanne ^a   Rhoades, Elizabeth R ^a   Keen, Marc ^a   Belisle, John T ^a   Frank, Anthony A ^a   Orme, Ian M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL OVERGROWTH; BCG VACCINATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GUINEA PIG; HISTOPATHOLOGY; IMMUNOTHERAPY; INFECTION PREVENTION; INOCULATION; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; BCG VACCINE; FEMALE; LUNG; MICE; MICE, INBRED C57BL; TUBERCULOSIS; VACCINATION;

EID: 0033970123     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1706-1709.2000     Document Type: Article

References (17)

1. Baldwin, S. L., C. D'Souza, A. D. Roberts, B. P. Kelly, A. A. Frank, M. A. Lui, J. B. Ulmer, K. Huygen, D. M. McMurray, and I. M. Orme. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
2. Belisle, J. T., V. D. Vissa, T. Sievert, K. Takayama, P. J. Brennan, and G. S. Besra. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422.
3. D'Souza, C. D., A. M. Cooper, A. A. Frank, R. J. Mazzaccaro, B. R. Bloom, and I. M. Orme. 1997. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158:1217-1221.
4. Fine, P. E. 1998. Vaccines, genes and trials. Novartis Found. Symp. 217:57-69.
5. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
6. Lowrie, D. B., R. E. Tascon, V. L. Bonato, V. M. Lima, L. H. Faccioli, E. Stavropoulos, M. J. Colston, R. G. Hewinson, K. Moelling, and C. L. Silva. 1999. Therapy of tuberculosis in mice by DNA vaccination. Nature 400:269-271.
7. Murray, P. J., L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315-321.
8. Orme, I. M. 1988. Antimycobacterial activity in vivo of LM427 (rifabutin). Am. Rev. Respir. Dis. 138:1254-1257.
9. Orme, I. M. 1999. New vaccines against tuberculosis. The status of current research. Infect. Dis. Clin. N. Am. 13:169-185, vii-viii.
10. Orme, I. M. 1997. Progress in the development of new vaccines against tuberculosis. Int. J. Tuberc. Lung Dis. 1:95-100.
11. Orme, I. M. 1999. Vaccination against tuberculosis: recent progress. Adv. Vet. Med. 41:135-143.
12. Orme, I. M., and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 20:307-312.
13. Rhoades, E. R., A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78:57-66.
14. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502-508.
15. Rodrigues, L. C., and P. G. Smith. 1990. Tuberculosis in developing countries and methods for its control. Trans. R. Soc. Trop. Med. Hyg. 84:739-744.
16. Sterne, J. A., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2:200-207.
17. Toossi, Z., and J. J. Ellner. 1998. The role of TGF beta in the pathogenesis of human tuberculosis. Clin. Immunol. Immunopathol. 87:107-114.